標(biāo)題: Titlebook: Breast Pathology; Problematic Issues Sami Shousha Book 2017 Springer International Publishing Switzerland 2017 breast cancer.breast carcino [打印本頁] 作者: 帳簿 時(shí)間: 2025-3-21 17:02
書目名稱Breast Pathology影響因子(影響力)
書目名稱Breast Pathology影響因子(影響力)學(xué)科排名
書目名稱Breast Pathology網(wǎng)絡(luò)公開度
書目名稱Breast Pathology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Breast Pathology被引頻次
書目名稱Breast Pathology被引頻次學(xué)科排名
書目名稱Breast Pathology年度引用
書目名稱Breast Pathology年度引用學(xué)科排名
書目名稱Breast Pathology讀者反饋
書目名稱Breast Pathology讀者反饋學(xué)科排名
作者: Allowance 時(shí)間: 2025-3-21 23:46
Grading of Invasive Carcinoma, its intrinsic biological characteristics. It has a strong correlation with prognosis. This chapter deals with the basic principles of grading, its methodology, and evidence supporting its importance in clinical practice.作者: 膽小鬼 時(shí)間: 2025-3-22 00:50
Fibroepithelial Lesions,adenoma and distinction of malignant phyllodes from breast sarcomas and spindle cell carcinoma in both surgical specimens and needle core biopsy. The genetics of both lesions and prognostic factors of phyllodes tumor are also discussed.作者: CROW 時(shí)間: 2025-3-22 06:16
Mucinous Lesions of the Breast and Expression of WT1,ma at the other end and include mucocele-like lesions and mucinous DCIS. All lesions are characterized by the presence of abundant, usually acidic, mucin, and the majority express WT1. There is also a discussion of reporting mucocele-like lesions in core biopsies and a brief account of signet ring cell carcinoma.作者: 緩解 時(shí)間: 2025-3-22 11:50
Spindle Cell Lesions,e dealt with in Chaps. 12 and 8, respectively. It starts with outlining the scheme that should be followed for diagnosing spindle cell lesions in core biopsies. Important benign and malignant lesions are then discussed individually.作者: Agility 時(shí)間: 2025-3-22 13:08 作者: bleach 時(shí)間: 2025-3-22 18:10 作者: Chronic 時(shí)間: 2025-3-22 22:22
Sketches on Developing SpecializationsLobular neoplasia includes atypical lobular hyperplasia and lobular carcinoma in situ. This chapter details the morphological and immunohistochemical characteristics of in situ lobular neoplasia and its rarer variants with emphasis on diagnostic challenges, significance, and management.作者: FUSE 時(shí)間: 2025-3-23 02:36
The Business Convergence Hypothesis,This chapter deals with some of the uncommon breast lesions that can be encountered during routine daily practice and need differentiating from malignant lesions.作者: Ligament 時(shí)間: 2025-3-23 06:15
https://doi.org/10.1007/978-3-319-00569-0Twelve selected rare types of malignant breast lesions are presented, described, and illustrated.作者: 安心地散步 時(shí)間: 2025-3-23 12:35 作者: Cryptic 時(shí)間: 2025-3-23 14:38
Uncommon Benign Breast Lesions,This chapter deals with some of the uncommon breast lesions that can be encountered during routine daily practice and need differentiating from malignant lesions.作者: Mumble 時(shí)間: 2025-3-23 18:05
Uncommon Malignant Lesions,Twelve selected rare types of malignant breast lesions are presented, described, and illustrated.作者: Encumber 時(shí)間: 2025-3-24 00:09
https://doi.org/10.1007/978-3-031-09962-5ypical ductal hyperplasia, columnar cell lesions, and flat epithelial atypia. In situ malignant lesions are mentioned briefly, and criteria for distinguishing them from benign and atypical proliferative lesions are discussed.作者: corpuscle 時(shí)間: 2025-3-24 06:24
Management Information from Data Bases its intrinsic biological characteristics. It has a strong correlation with prognosis. This chapter deals with the basic principles of grading, its methodology, and evidence supporting its importance in clinical practice.作者: 痛恨 時(shí)間: 2025-3-24 07:25
https://doi.org/10.1007/978-1-349-16344-1adenoma and distinction of malignant phyllodes from breast sarcomas and spindle cell carcinoma in both surgical specimens and needle core biopsy. The genetics of both lesions and prognostic factors of phyllodes tumor are also discussed.作者: GRIEF 時(shí)間: 2025-3-24 13:17
Marta Peris-Ortiz,José-Luis Hervás-Oliverma at the other end and include mucocele-like lesions and mucinous DCIS. All lesions are characterized by the presence of abundant, usually acidic, mucin, and the majority express WT1. There is also a discussion of reporting mucocele-like lesions in core biopsies and a brief account of signet ring cell carcinoma.作者: correspondent 時(shí)間: 2025-3-24 16:46
José-Luis Hervás-Oliver,Marta Peris-Ortize dealt with in Chaps. 12 and 8, respectively. It starts with outlining the scheme that should be followed for diagnosing spindle cell lesions in core biopsies. Important benign and malignant lesions are then discussed individually.作者: 游行 時(shí)間: 2025-3-24 22:16
https://doi.org/10.1007/978-981-19-9231-5es in diagnosis. As a “triple-negative” carcinoma, it falls within the “basal-like” phenotype of breast carcinomas. Immunohistochemistry is almost always essential in the diagnostic workup, and the differential diagnosis of metaplastic carcinoma on core biopsy is broad and includes both benign and malignant spindle cell lesions of the breast.作者: 易怒 時(shí)間: 2025-3-25 01:06
Management Innovation and Big Datarinciples and quality assurance issues that should be followed concerning tissue fixation and processing and result interpretation. Various antibodies used for the diagnosis of breast diseases including those used for providing prognostic and predictive information are then dealt with individually supported by ample illustrations.作者: archetype 時(shí)間: 2025-3-25 06:49 作者: CRUC 時(shí)間: 2025-3-25 09:35
http://image.papertrans.cn/b/image/190615.jpg作者: 格言 時(shí)間: 2025-3-25 14:34 作者: Recessive 時(shí)間: 2025-3-25 17:28
https://doi.org/10.1007/978-3-031-09962-5ly breast cancer with aggressive biological and clinical features and may result in tumor downsizing allowing breast conservation in patients who would otherwise require mastectomy. Tumor response to neoadjuvant therapy is an important prognostic factor and is increasingly being used to guide clinic作者: 牽連 時(shí)間: 2025-3-25 23:26
https://doi.org/10.1007/978-3-031-09962-5ypical ductal hyperplasia, columnar cell lesions, and flat epithelial atypia. In situ malignant lesions are mentioned briefly, and criteria for distinguishing them from benign and atypical proliferative lesions are discussed.作者: 縮減了 時(shí)間: 2025-3-26 00:52
Sketches on Developing Specializationsistological microcalcifications. The use of reporting categories (“B” codes) is recommended, and the chapter largely concentrates on those entities causing diagnostic difficulties, such as the B3 lesions, of uncertain malignant potential, as well as potentially problematic malignant lesions, albeit 作者: 天賦 時(shí)間: 2025-3-26 08:11 作者: 等級(jí)的上升 時(shí)間: 2025-3-26 11:23 作者: Disk199 時(shí)間: 2025-3-26 13:35
https://doi.org/10.1007/978-1-349-16344-1adenoma and distinction of malignant phyllodes from breast sarcomas and spindle cell carcinoma in both surgical specimens and needle core biopsy. The genetics of both lesions and prognostic factors of phyllodes tumor are also discussed.作者: ingrate 時(shí)間: 2025-3-26 19:20
Marta Peris-Ortiz,José-Luis Hervás-Oliverma at the other end and include mucocele-like lesions and mucinous DCIS. All lesions are characterized by the presence of abundant, usually acidic, mucin, and the majority express WT1. There is also a discussion of reporting mucocele-like lesions in core biopsies and a brief account of signet ring c作者: 假 時(shí)間: 2025-3-26 23:20
José-Luis Hervás-Oliver,Marta Peris-Ortize dealt with in Chaps. 12 and 8, respectively. It starts with outlining the scheme that should be followed for diagnosing spindle cell lesions in core biopsies. Important benign and malignant lesions are then discussed individually.作者: 障礙物 時(shí)間: 2025-3-27 02:19 作者: 發(fā)芽 時(shí)間: 2025-3-27 07:22
https://doi.org/10.1007/978-981-19-9231-5es in diagnosis. As a “triple-negative” carcinoma, it falls within the “basal-like” phenotype of breast carcinomas. Immunohistochemistry is almost always essential in the diagnostic workup, and the differential diagnosis of metaplastic carcinoma on core biopsy is broad and includes both benign and m作者: 羽毛長成 時(shí)間: 2025-3-27 11:05 作者: 機(jī)警 時(shí)間: 2025-3-27 14:38 作者: 摻和 時(shí)間: 2025-3-27 21:40
Management Innovation and Big Datarinciples and quality assurance issues that should be followed concerning tissue fixation and processing and result interpretation. Various antibodies used for the diagnosis of breast diseases including those used for providing prognostic and predictive information are then dealt with individually s作者: Trypsin 時(shí)間: 2025-3-28 00:24
https://doi.org/10.1057/9780230227439w insights into the molecular heterogeneity of breast cancer. This has redefined how we classify breast cancer and offers the potential to revolutionize patient management through more precise determination of prognosis based on tumor biology and the opportunity for targeted treatments directed at t作者: 臭名昭著 時(shí)間: 2025-3-28 03:29
https://doi.org/10.1007/978-3-319-00569-0s the commonest cause of male breast lump. Most of the lesions are idiopathic, but enlargement due to various physiological and pathological causes may occur. The lesions histologically show florid epithelial proliferation within a cellular stroma in the early (active) phase and fibrosis with minima作者: Cleave 時(shí)間: 2025-3-28 09:17
https://doi.org/10.1007/978-3-319-28655-6breast cancer; breast carcinoma; breast lesion; breast pathology; breast tumor作者: Ovulation 時(shí)間: 2025-3-28 12:29
978-3-319-80400-2Springer International Publishing Switzerland 2017作者: machination 時(shí)間: 2025-3-28 17:12 作者: 巧思 時(shí)間: 2025-3-28 21:30 作者: 增減字母法 時(shí)間: 2025-3-29 02:36 作者: AGGER 時(shí)間: 2025-3-29 03:30
Book 2017ealing with the gross specimens derived from patients treated with conservative surgery and those who had neo-adjuvant therapy before surgery. It also discusses how to deal with axillary lymph nodes, proliferative breast lesions, including DCIS, and problematic core biopsies, as well as fibro-epithe作者: 維持 時(shí)間: 2025-3-29 08:25 作者: bioavailability 時(shí)間: 2025-3-29 14:50
https://doi.org/10.1057/9780230227439he specific molecular aberrations driving tumor growth. This chapter describes models for the molecular classification of breast cancer, current genetic signatures available for predicting prognosis, and future prospects for monitoring disease and response to therapy.作者: PALMY 時(shí)間: 2025-3-29 18:19 作者: insincerity 時(shí)間: 2025-3-29 21:16 作者: Inveterate 時(shí)間: 2025-3-30 02:28
Sketches on Developing Specializationsusing diagnostic difficulties, such as the B3 lesions, of uncertain malignant potential, as well as potentially problematic malignant lesions, albeit these make up a minority of a pathologist’s routine practice.作者: 獎(jiǎng)牌 時(shí)間: 2025-3-30 06:37
https://doi.org/10.1007/978-3-031-09962-5histochemistry to confirm the diagnosis in certain situations. There is also a discussion of rare types of DCIS as well as DCIS arising in the context of columnar cell change and following neoadjuvant therapy.作者: seduce 時(shí)間: 2025-3-30 08:43
Management Innovation and Big Dataastatic ovarian carcinoma from primary breast carcinoma is discussed in more detail, as well as differentiating metastatic neuroendocrine tumors from primary breast carcinomas with neuroendocrine differentiation.作者: 抗體 時(shí)間: 2025-3-30 13:11
Management Innovation and Big Dataarance depending on the result of the provisional node assessment. Methods for dealing with these different biopsy types are discussed. The chapter ends with a discussion of carcinoma of unknown primary (CUP) origin occasionally seen in axillary lymph nodes.作者: Compatriot 時(shí)間: 2025-3-30 19:27
Dealing with the Gross Specimen,adjuvant chemotherapy, and axillary lymph node specimens are dealt with in other Chaps. (4, 5, 2, and 14, respectively). The accounts in this chapter are mainly based on the practice at Charing Cross Hospital, London.作者: Panacea 時(shí)間: 2025-3-30 22:01
Problematic Core Biopsies,using diagnostic difficulties, such as the B3 lesions, of uncertain malignant potential, as well as potentially problematic malignant lesions, albeit these make up a minority of a pathologist’s routine practice.作者: Tailor 時(shí)間: 2025-3-31 01:17 作者: 惡意 時(shí)間: 2025-3-31 06:41 作者: 全能 時(shí)間: 2025-3-31 10:44
Axillary Lymph Node Biopsies,arance depending on the result of the provisional node assessment. Methods for dealing with these different biopsy types are discussed. The chapter ends with a discussion of carcinoma of unknown primary (CUP) origin occasionally seen in axillary lymph nodes.作者: endure 時(shí)間: 2025-3-31 13:51 作者: MOT 時(shí)間: 2025-3-31 18:03
Molecular Classification and Testing of Breast Carcinoma,he specific molecular aberrations driving tumor growth. This chapter describes models for the molecular classification of breast cancer, current genetic signatures available for predicting prognosis, and future prospects for monitoring disease and response to therapy.作者: 夾死提手勢 時(shí)間: 2025-4-1 00:06
Dealing with the Gross Specimen,g with other specimens is also briefly discussed as dealing with core biopsies, specimens from patients with DCIS, specimens from patients who had neoadjuvant chemotherapy, and axillary lymph node specimens are dealt with in other Chaps. (4, 5, 2, and 14, respectively). The accounts in this chapter 作者: GREEN 時(shí)間: 2025-4-1 03:45
Handling Neoadjuvant Therapy Specimens,ly breast cancer with aggressive biological and clinical features and may result in tumor downsizing allowing breast conservation in patients who would otherwise require mastectomy. Tumor response to neoadjuvant therapy is an important prognostic factor and is increasingly being used to guide clinic作者: 大方不好 時(shí)間: 2025-4-1 08:53
Proliferative Breast Lesions,ypical ductal hyperplasia, columnar cell lesions, and flat epithelial atypia. In situ malignant lesions are mentioned briefly, and criteria for distinguishing them from benign and atypical proliferative lesions are discussed.作者: metropolitan 時(shí)間: 2025-4-1 13:49
